Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019063844) RESPIRATORY SYNCYTIAL VIRUS VACCINATION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/063844 International Application No.: PCT/EP2018/076669
Publication Date: 04.04.2019 International Filing Date: 01.10.2018
IPC:
A61K 39/155 (2006.01) ,C07K 14/005 (2006.01) ,C07K 14/135 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
12
Viral antigens
155
Paramyxoviridae, e.g. parainfluenza virus
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005
from viruses
01
DNA viruses
03
Herpetoviridae, e.g. pseudorabies virus
05
Epstein-Barr virus
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005
from viruses
08
RNA viruses
115
Paramyxoviridae, e.g. parainfluenza virus
135
Respiratory syncytial virus
Applicants:
UNIVERSITEIT ANTWERPEN [BE/BE]; Prinsstraat 13 2000 Antwerpen, BE
Inventors:
DELPUTTE, Peter; BE
LEEMANS, Annelies; BE
Agent:
LC PATENTS; Kempische Steenweg 542A 3500 Hasselt, BE
Priority Data:
17194098.429.09.2017EP
Title (EN) RESPIRATORY SYNCYTIAL VIRUS VACCINATION
(FR) VACCINATION CONTRE LE VIRUS RESPIRATOIRE SYNCYTIAL
Abstract:
(EN) The present invention in general relates to novel respiratory syncytial virus (RSV) F nucleic acids and (glyco)proteins or peptides encoded therefrom. It further provides vaccines comprising such nucleic acids, (glyco)proteins or peptides, as well as uses thereof in the prophylaxis and/or treatment of RSV infections.
(FR) La présente invention concerne en général de nouveaux acides nucléiques et (glyco)protéines du virus respiratoire syncytial (VRS) ou des peptides codés à partir de ceux-ci. L'invention concerne en outre des vaccins comprenant de tels acides nucléiques, (glyco) protéines ou peptides, ainsi que leurs utilisations dans la prophylaxie et/ou le traitement d'infections par le VRS.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)